Responses
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
THU0169 Can Baseline (Anti-)Infliximab Serum Trough Levels Predict Successful Down-Titration or Discontinuation of Infliximab in Rheumatoid Arthritis Patients with Long Term Low Disease Activity?
Compose a Response to This Article
Other responses
No responses have been published for this article.